A Phase 1 study of Nezavist in healthy adults
Terminated Phase 1 NCT06633562
Study Description
A study to evaluate the safety and effects of different doses of Nezavist in healthy volunteers
Study Details
- Registry ID:
- NCT06633562
- Conditions:
- Healthy, Safety Evaluation of Escalating Doses, Tolerability
- Phase:
- Phase 1
- Target Enrollment:
- 29 participants
- Start Date:
- Age Range:
- 18–55 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
The Altman Clinical and Translational Research Institute
La Jolla, California, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.